RVPH – reviva pharmaceuticals holdings, inc. (US:NASDAQ)

News

Reviva Reports Third Quarter 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]
Reviva Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Reviva Announces Enrollment Update for Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia
Reviva to Present Positive Speech Latency Data for Brilaroxazine in Schizophrenia From the Phase 3 RECOVER Trial at the CNS Summit 2024
Reviva to Participate in the UBS Global Healthcare Conference
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com